Report: New FDA guidance release rate falls post-Trump election


Trump FDA pick to recuse himself from agency decisions involving 20 companiesThe FDA hoped to release more than 100 draft guidance documents this year, but has only released 6 documents since Trump’s inauguration, according to a Regulatory Affairs Professional Society’s Regulatory Focus report.

Since January 20, nearly 3 months ago, the agency has only released 2 guidance documents and 4 final guidances, according to the report.

Read the whole story on our sister site,

How do you know your technology is disruptive enough to break conventional wisdom?

textadimage Stan Rowe knows a little something about bringing disruptive technology to market. The current Edwards Lifesciences CSO was in on the ground floor of two of medtech's most disruptive treatments, stents and transcatheter aortic valve replacement.

On December 12th, Rowe will sit down with MassDevice editor Brad Perriello for a long ranging discussion about the inside story on how these technologies came to market and what Rowe learned along the way.

Register now with the code "TAVR" and save 15% today.

Speak Your Mind